Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting.
Level V
Where this comes from
- Record sourced from PubMed, PMID 38167394.
- Also identified by DOI 10.3949/ccjm.91a.23015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gastric intestinal metaplasia (GIM), a common histologic finding, is associated with increased risk of gastric cancer, and GIM associated with <i>Helicobacter pylori</i> infection is classified as an environmental metaplastic atrophic gastritis. Patients may be asymptomatic or present with various dyspeptic symptoms. Autoimmune metaplastic atrophic gastritis is a less common but important cause of chronic gastritis. The Correa cascade describes the evolution of precancerous mucosal changes that lead to development of GIM, with differentiation of 2 histologic types of GIM (complete and incomplete) and the consequences of each type. The risk of progression to malignancy is higher with incomplete GIM. It is also higher for those who immigrate from regions with a high incidence of <i>H pylori</i> infection to areas where the incidence is low. Guidelines regarding endoscopic management of GIM vary by geographic region.
Medical subject headings
- Stomach Neoplasms
- Gastritis, Atrophic
- Helicobacter Infections
- Helicobacter pylori
- Gastritis
- Precancerous Conditions